0

Diabetes Collection
 161-180 of 791 Articles
Ideas and Opinions |  4 March 2003
Importance of Identifying the Overweight Patient Who Will Benefit the Most by Losing Weight
Gerald M. Reaven, MD
Ann Intern Med. 2003;138(5):420-423. doi:10.7326/0003-4819-138-5-200303040-00012
Supplement: The Future of Primary Care |  4 February 2003
Chronic Illness Management: What Is the Role of Primary Care?
Arlyss Anderson Rothman, PhD, MHS; Edward H. Wagner, MD, MPH
Ann Intern Med. 2003;138(3):256-261. doi:10.7326/0003-4819-138-3-200302040-00034
Articles |  7 January 2003 FREE
Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial
Alka M. Kanaya, MD; David Herrington, MD, MHS; Eric Vittinghoff, PhD; et al.
Ann Intern Med. 2003;138(1):1-9. doi:10.7326/0003-4819-138-1-200301070-00005
Editorials |  7 January 2003
Lower Diabetes Risk with Hormone Replacement Therapy: An Encore for Estrogen?
Peter W.F. Wilson, MD
Ann Intern Med. 2003;138(1):69-70. doi:10.7326/0003-4819-138-1-200301070-00015
Academia and the Profession |  20 August 2002
Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus
R Graham Barr, MD, MPH; David M. Nathan, MD; James B. Meigs, MD, MPH; et al.
Ann Intern Med. 2002;137(4):263-272. doi:10.7326/0003-4819-137-4-200208200-00011
Editorials |  20 August 2002
Articles on Diagnostic Tests: A New Series and an Invitation to Authors
Alan M. Garber, MD, PhD; Cynthia Mulrow, MD, MPH, Deputy Editor; Harold C. Sox, MD, Editor
Ann Intern Med. 2002;137(4):288-289. doi:10.7326/0003-4819-137-4-200208200-00014
Academia and the Profession |  16 July 2002 FREE
Unexpected Hypoglycemia in a Critically Ill Patient
David W. Bates, MD, MSc*
Ann Intern Med. 2002;137(2):110-116. doi:10.7326/0003-4819-137-2-200207160-00009
Therapeutics |  May/Jun 2002
Review: Exercise training reduces HbA1c levels but not body mass in type 2 diabetes mellitus
Paul Franks, MSc, MPhil; Simon Griffin, MSc, DM, MRCGP
Ann Intern Med. 2002;136(3):100. doi:10.7326/ACPJC-2002-136-3-100
Therapeutics |  May/Jun 2002
Overall satisfaction increased more with inhaled insulin than with subcutaneous insulin in type 1 diabetes
Rudy Bilous, MD
Ann Intern Med. 2002;136(3):101. doi:10.7326/ACPJC-2002-136-3-101
Prognosis |  May/Jun 2002
Review: Stress hyperglycemia after ischemic stroke indicates a greater risk for death in patients without diabetes
James Douketis, MD
Ann Intern Med. 2002;136(3):114. doi:10.7326/ACPJC-2002-136-3-114
Clinical Prediction Guide |  May/Jun 2002
Several simple rules predicted complications in high-risk patients with diabetes
Steven Smith, MD
Ann Intern Med. 2002;136(3):117. doi:10.7326/ACPJC-2002-136-3-117
Therapeutics |  May/Jun 2002
Intensive insulin therapy reduced mortality and morbidity in critically ill patients
Daniel L. Hurley, MD; M. Molly McMahon, MD
Ann Intern Med. 2002;136(3):81. doi:10.7326/ACPJC-2002-136-3-081
Therapeutics |  May/Jun 2002
Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):82. doi:10.7326/ACPJC-2002-136-3-082
Therapeutics |  May/Jun 2002
Irbesartan reduced progression of nephropathy caused by type 2 diabetes independent of the effect on blood pressure
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):83. doi:10.7326/ACPJC-2002-136-3-083
Therapeutics |  May/Jun 2002
Losartan was renoprotective in diabetic nephropathy independent of its effect on blood pressure
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):84. doi:10.7326/ACPJC-2002-136-3-084
Articles |  16 April 2002 FREE
A Diabetes Report Card for the United States: Quality of Care in the 1990s
Jinan B. Saaddine, MD; Michael M. Engelgau, MD; Gloria L. Beckles, MD; et al.
Ann Intern Med. 2002;136(8):565-574. doi:10.7326/0003-4819-136-8-200204160-00005
Articles |  16 April 2002
Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test?
Michael P. Stern, MD; Ken Williams, MS; Steven M. Haffner, MD, MPH
Ann Intern Med. 2002;136(8):575-581. doi:10.7326/0003-4819-136-8-200204160-00006
Articles |  2 April 2002
Administration of Neutral Protamine Hagedorn Insulin at Bedtime versus with Dinner in Type 1 Diabetes Mellitus To Avoid Nocturnal Hypoglycemia and Improve Control: A Randomized, Controlled Trial
Carmine G. Fanelli, MD, PhD; Simone Pampanelli, MD; Francesca Porcellati, MD, PhD; et al.
Ann Intern Med. 2002;136(7):504-514. doi:10.7326/0003-4819-136-7-200204020-00007
Editorials |  2 April 2002
Avoiding Nocturnal Hypoglycemia: Consideration of an Extra Injection at Bedtime
Andrew W. Norris, MD, PhD; Lori M.B. Laffel, MD, MPH
Ann Intern Med. 2002;136(7):547-549. doi:10.7326/0003-4819-136-7-200204020-00013
Articles |  5 February 2002
Dietary Patterns and Risk for Type 2 Diabetes Mellitus in U.S. Men
Rob M. van Dam, MSc; Eric B. Rimm, ScD; Walter C. Willett, MD; et al.
Ann Intern Med. 2002;136(3):201-209. doi:10.7326/0003-4819-136-3-200202050-00008
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)